Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/03/2012 | US20120110706 Modified bacillus thuringiensis cry21 proteins for nematode control |
05/03/2012 | US20120110697 Method of constructing novel higher plant and method of promoting the growth of higher plant |
05/03/2012 | US20120110694 Plant myb transcription factor homologs |
05/03/2012 | US20120110685 Modular dna-binding domains and methods of use |
05/03/2012 | US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
05/03/2012 | US20120108792 Process and system for obtaining botulinum neurotoxin |
05/03/2012 | US20120108791 Rotamer Libraries and Methods of Use Thereof |
05/03/2012 | US20120108790 Truncated Somatostatin Receptors |
05/03/2012 | US20120108789 High affinity binding site of HGFR and methods for identification of antagonists thereof |
05/03/2012 | US20120108657 Disease-associated protein |
05/03/2012 | US20120108548 Molecular tweezers for the treatment of amyloid-related diseases |
05/03/2012 | US20120108523 Disease-associated protein |
05/03/2012 | US20120108521 Immunostimulatory compositions and uses thereof |
05/03/2012 | US20120108519 Neo-tryptophan |
05/03/2012 | US20120108516 The use of midkine protein and the protein-containing medical device |
05/03/2012 | US20120108512 Stable pharmaceutical compositions of peptide derivatized using an oxime linker |
05/03/2012 | US20120108504 Leptin agonist and methods of use |
05/03/2012 | US20120108493 Polypeptide Fragments Comprising Endonuclease Activity and Their Use |
05/03/2012 | US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof |
05/03/2012 | US20120107911 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same |
05/03/2012 | US20120107876 Novel fusion tag offering solubility to insoluble recombinant protein |
05/03/2012 | US20120107874 Modified Host Cells and Uses Thereof |
05/03/2012 | US20120107868 Processes for making protein hydrolysates from animal peptone and for preserving mucosa |
05/03/2012 | US20120107867 Glycopegylated erythropoietin |
05/03/2012 | US20120107857 Di- and Poly-Ubiquitin Deubiquitinase Substrates and Uses Thereof |
05/03/2012 | US20120107855 Crosslinking reagent for analysis of protein-protein interaction |
05/03/2012 | US20120107852 Method for preparing modified polypeptides |
05/03/2012 | US20120107802 Method for sequencing a heteropolymeric target nucleic acid sequence |
05/03/2012 | US20120107798 Single molecule sensitive probes for detecting rna |
05/03/2012 | US20120107484 PRODUCTION OF CANOLA PROTEIN PRODUCT WITHOUT HEAT TREATMENT ("C200CaC") |
05/03/2012 | US20120107390 Feline infectious peritonitis vaccine |
05/03/2012 | US20120107372 Recombinant gelatins |
05/03/2012 | US20120107363 Immunogen against campylobacter infection |
05/03/2012 | US20120107362 Neurotoxins exhibiting shortened biological activity |
05/03/2012 | US20120107358 Subgenomic replicons of the flavivirus dengue |
05/03/2012 | US20120107357 Novel divergent picornavirus: cosavirus |
05/03/2012 | US20120107345 Manufacture of vaccines that contain both hepatitis b virus surface antigens and surfactant |
05/03/2012 | US20120107343 Production of recombinant proteins in ciliates and uses thereof |
05/03/2012 | US20120107340 Compositions for immunising against staphylococcus aureus |
05/03/2012 | US20120107339 Chimeric Factor H Binding Proteins (fHBP) Containing a Heterologous B Domain and Methods of Use |
05/03/2012 | US20120107338 Identification of a novel retrovirus in patients with benign prostatic hyperplasia |
05/03/2012 | US20120107336 Modified defensins and their use |
05/03/2012 | US20120107334 Method for enhancing immune response with peptide |
05/03/2012 | US20120107324 TARGETED BINDING AGENTS DIRECTED TO a5ß1 AND USES THEREOF |
05/03/2012 | US20120107322 Immunogenic and therapeutic compositions for streptococcus pyogenes |
05/03/2012 | US20120107313 Mammalian receptor proteins; related reagents and methods |
05/03/2012 | US20120107283 Human skin equivalents expressing exogenous polypeptides |
05/03/2012 | US20120107267 Interleukin-21 variants having antagonistic binding to the il-21 receptor |
05/03/2012 | US20120107247 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their Use as Diagnostic Reagents and Vaccines |
05/03/2012 | US20120107244 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611 |
05/03/2012 | US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier |
05/03/2012 | US20120104656 Biopolymer Materials |
05/03/2012 | CA2819230A1 Methods and compositions for assessing and treating cancer |
05/03/2012 | CA2819117A1 Anti-sod1 antibodies and uses thereof |
05/03/2012 | CA2816379A1 Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies |
05/03/2012 | CA2816306A1 Isoprene synthase variants for improved production of isoprene |
05/03/2012 | CA2816190A1 Methods for capturing virus like particles from plants using expanded bed chromatography |
05/03/2012 | CA2816175A1 Diketopiperazine forming dipeptidyl linker |
05/03/2012 | CA2816050A1 Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli |
05/03/2012 | CA2815888A1 Clostridium difficile-specific antibodies and uses thereof |
05/03/2012 | CA2815267A1 Spider silk fusion protein structures for binding to an organic target |
05/03/2012 | CA2815239A1 Fviii peptides for immune tolerance induction and immunodiagnostics |
05/03/2012 | CA2815140A1 Glucose-dependent insulinotropic peptide analogs |
05/02/2012 | EP2447364A1 Modified biotin-conjugated protein |
05/02/2012 | EP2447360A1 Gene defects and mutant ALK kinase in human solid tumors |
05/02/2012 | EP2447359A1 Gene defects and mutant ALK kinase in human solid tumors |
05/02/2012 | EP2447280A2 VEGF analogs and methods of use |
05/02/2012 | EP2447279A1 Methods and compositions for gene inactivation |
05/02/2012 | EP2447278A1 Novel immunogenic proteins of Leptospira |
05/02/2012 | EP2447277A1 Vaccine compositions based on modified gp41 immunogens |
05/02/2012 | EP2447055A1 Silk biomaterials and methods of use thereof |
05/02/2012 | EP2446897A1 Anti-KIR combination treatments and methods |
05/02/2012 | EP2446886A1 Autophagy regulators and the uses thereof in the treatment of collagen VI defective Muscular Dystrophies |
05/02/2012 | EP2446862A2 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
05/02/2012 | EP2446051A1 Shoc2 mutations causing noonan-like syndrome with loose anagen hair |
05/02/2012 | EP2446038A1 Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin |
05/02/2012 | EP2445935A1 Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof |
05/02/2012 | EP2445934A2 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof |
05/02/2012 | EP2445933A1 Avian colony stimulating factor 1 receptor binding proteins |
05/02/2012 | EP2445932A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery |
05/02/2012 | EP2445931A2 Mutant stabilised g-protein coupled receptors, their uses and methods for producing them |
05/02/2012 | EP2445930A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
05/02/2012 | EP2445929A1 A method for transforming a bacterium belonging to the streptococcus genus by natural competence |
05/02/2012 | EP2445928A1 Chimeric influenza virus-like particles comprising hemagglutinin |
05/02/2012 | EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions |
05/02/2012 | EP2445526A1 Recombinant rsv antigens |
05/02/2012 | EP2445525A2 Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease |
05/02/2012 | EP2445515A2 Antimicrobial agents |
05/02/2012 | EP2124993B1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
05/02/2012 | EP1993603B1 Hepatitis c virus non structural fusion protein |
05/02/2012 | EP1948226B1 A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif |
05/02/2012 | EP1924597B1 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
05/02/2012 | EP1804835B9 Multimeric constructs |
05/02/2012 | EP1678200B1 A method of modulating cell survival, differentiation and/or synaptic plasticity |
05/02/2012 | EP1634951B1 Novel protein |
05/02/2012 | EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
05/02/2012 | EP1343822B1 Means for the diagnosis and therapy of ctcl |
05/02/2012 | CN1902315B Endoglucanase STCE and cellulase preparation containing the same |
05/02/2012 | CN1815234B Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof |
05/02/2012 | CN1231673B Polynucleotide and its use for modulating a defence response in plants |